In a therapeutic setting, the quantification of Ki-67 indices revealed significant anti-proliferative effects of adavosertib, a small molecular Wee1-inhibitor, against MUC-1 but not NCI-H295R tumor spheroids (Fig. 3K, L). Here, MKI67 is linked to neoplasm.